Case Study: Dana-Farber Cancer Institute expands hereditary cancer risk screening with Kanda Software's PREMMplus platform

Dana-Farber Cancer Institute launches PREMMplus with Kanda, reaching 89-94% sensitivity

Dana-Farber Cancer Institute faced the challenge of scaling its clinically validated PREMMplus hereditary cancer risk algorithm beyond a research tool into a secure, accessible platform. They needed a solution that could serve diverse users, from patients to major health systems, while maintaining strict data boundaries and compliance. Kanda Software was engaged to build this scalable platform.

Kanda Software developed a cloud-native, API-first architecture that created two distinct environments: a public website with no data retention and a secure, multi-tenant licensed platform for healthcare organizations. This solution successfully expanded access to the risk assessment tool, which boasts 89-94% sensitivity and greater than 97% negative predictive value, enabling more individuals to be identified for potentially life-saving genetic testing.

Dana-Farber Cancer Institute